These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23637827)

  • 21. The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice.
    Forero A; Tisoncik-Go J; Watanabe T; Zhong G; Hatta M; Tchitchek N; Selinger C; Chang J; Barker K; Morrison J; Berndt JD; Moon RT; Josset L; Kawaoka Y; Katze MG
    J Virol; 2015 Dec; 90(5):2240-53. PubMed ID: 26656717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.
    Nogales A; Martinez-Sobrido L; Chiem K; Topham DJ; DeDiego ML
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses.
    Job ER; Deng YM; Barfod KK; Tate MD; Caldwell N; Reddiex S; Maurer-Stroh S; Brooks AG; Reading PC
    J Immunol; 2013 Mar; 190(5):2169-77. PubMed ID: 23365085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive Mutations That Occurred during Circulation in Humans of H1N1 Influenza Virus in the 2009 Pandemic Enhance Virulence in Mice.
    Otte A; Sauter M; Daxer MA; McHardy AC; Klingel K; Gabriel G
    J Virol; 2015 Jul; 89(14):7329-37. PubMed ID: 25948752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemagglutinin mutation D222N of the 2009 pandemic H1N1 influenza virus alters receptor specificity without affecting virulence in mice.
    Kong W; Liu L; Wang Y; Gao H; Wei K; Sun H; Sun Y; Liu J; Ma G; Pu J
    Virus Res; 2014 Aug; 189():79-86. PubMed ID: 24818619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaption of seasonal H1N1 influenza virus in mice.
    Xu L; Bao L; Li F; Lv Q; Ma Y; Zhou J; Xu Y; Deng W; Zhan L; Zhu H; Ma C; Shu Y; Qin C
    PLoS One; 2011; 6(12):e28901. PubMed ID: 22194944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin.
    Igarashi M; Ito K; Yoshida R; Tomabechi D; Kida H; Takada A
    PLoS One; 2010 Jan; 5(1):e8553. PubMed ID: 20049332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in transmissibility and pathogenicity of reassortants between H9N2 and 2009 pandemic H1N1 influenza A viruses from humans and swine.
    He L; Wu Q; Jiang K; Duan Z; Liu J; Xu H; Cui Z; Gu M; Wang X; Liu X; Liu X
    Arch Virol; 2014 Jul; 159(7):1743-54. PubMed ID: 24510170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Evolution of Influenza Virus NS1 Protein in Currently Circulating Human 2009 Pandemic H1N1 Viruses.
    Clark AM; Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.
    Tumpey TM; García-Sastre A; Taubenberger JK; Palese P; Swayne DE; Pantin-Jackwood MJ; Schultz-Cherry S; Solórzano A; Van Rooijen N; Katz JM; Basler CF
    J Virol; 2005 Dec; 79(23):14933-44. PubMed ID: 16282492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.
    Wanzeck K; Boyd KL; McCullers JA
    Am J Respir Crit Care Med; 2011 Mar; 183(6):767-73. PubMed ID: 20935106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses.
    Song MS; Pascua PN; Lee JH; Baek YH; Park KJ; Kwon HI; Park SJ; Kim CJ; Kim H; Webby RJ; Webster RG; Choi YK
    J Virol; 2011 Jul; 85(13):6275-86. PubMed ID: 21507962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus.
    Zhang Y; Zhang Q; Gao Y; He X; Kong H; Jiang Y; Guan Y; Xia X; Shu Y; Kawaoka Y; Bu Z; Chen H
    J Virol; 2012 Sep; 86(18):9666-74. PubMed ID: 22740390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin.
    Cline TD; Karlsson EA; Freiden P; Seufzer BJ; Rehg JE; Webby RJ; Schultz-Cherry S
    J Virol; 2011 Dec; 85(23):12262-70. PubMed ID: 21917948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the reconstructed 1918 Spanish influenza pandemic virus.
    Tumpey TM; Basler CF; Aguilar PV; Zeng H; Solórzano A; Swayne DE; Cox NJ; Katz JM; Taubenberger JK; Palese P; García-Sastre A
    Science; 2005 Oct; 310(5745):77-80. PubMed ID: 16210530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of PB1-F2 on the pathogenicity of H1N1 swine influenza virus in mice and pigs.
    Lee J; Henningson J; Ma J; Duff M; Lang Y; Li Y; Li Y; Nagy A; Sunwoo S; Bawa B; Yang J; Bai D; Richt JA; Ma W
    J Gen Virol; 2017 Jan; 98(1):31-42. PubMed ID: 28008819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
    Changsom D; Lerdsamran H; Wiriyarat W; Chakritbudsabong W; Siridechadilok B; Prasertsopon J; Noisumdaeng P; Masamae W; Puthavathana P
    PLoS One; 2016; 11(4):e0153183. PubMed ID: 27054879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry.
    Cruz E; Cain J; Crossett B; Kayser V
    Hum Vaccin Immunother; 2018 Mar; 14(3):508-517. PubMed ID: 29048990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.